Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

UNITED THERAPEUTICS (UTHR) Equity Ratio: 2009-2025

Historic Equity Ratio for UNITED THERAPEUTICS (UTHR) over the last 16 years, with Sep 2025 value amounting to 0.90.

  • UNITED THERAPEUTICS's Equity Ratio rose 4.67% to 0.90 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.90, marking a year-over-year increase of 4.67%. This contributed to the annual value of 0.88 for FY2024, which is 4.79% up from last year.
  • As of Q3 2025, UNITED THERAPEUTICS's Equity Ratio stood at 0.90, which was down 1.17% from 0.91 recorded in Q2 2025.
  • Over the past 5 years, UNITED THERAPEUTICS's Equity Ratio peaked at 0.91 during Q2 2025, and registered a low of 0.74 during Q1 2021.
  • Over the past 3 years, UNITED THERAPEUTICS's median Equity Ratio value was 0.85 (recorded in 2024), while the average stood at 0.85.
  • Data for UNITED THERAPEUTICS's Equity Ratio shows a peak YoY increased of 7.05% (in 2025) over the last 5 years.
  • Quarterly analysis of 5 years shows UNITED THERAPEUTICS's Equity Ratio stood at 0.77 in 2021, then increased by 3.61% to 0.79 in 2022, then climbed by 5.23% to 0.84 in 2023, then grew by 4.79% to 0.88 in 2024, then increased by 4.67% to 0.90 in 2025.
  • Its Equity Ratio was 0.90 in Q3 2025, compared to 0.91 in Q2 2025 and 0.88 in Q1 2025.